CRP and α-glycoprotein were also negatively correlated with CYP3A activity and cancer patients with significant acute-phase response may have reduced CYP3A drug metabolism, which may have implications for the safety and efficacy of chemotherapy (Rivory et al., 2002; Charles et al., 2006; Alexandre et al., 2007). This evidence concerns the gene CRP and cancer.